8 BioPharma Movers That Cannot Be Ignored
These biotech stocks 24/7 Wall St. has picked stood out from the rest with at least 25% gains over the course of the past week.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 240Janssen Secures Approval From FDA on New LPS and LMS Drug
ThinkstockJanssen Biotech announced that the U.S. Food and Drug Administration (FDA) approved Yondelis (trabectedin) for the treatment of patients with unresectable or metastatic liposarcoma (LPS) or leiomyosarcoma (LMS) who received a prior anthracycline-containing regimen.…
Centene Receives Overwhelming Approval to Acquire Health Net
ThinkstockFollowing a special shareholder meeting in St. Louis, Centene Corporation (NYSE: CNC) announced that its shareholders voted overwhelmingly to approve the issuance of Centene common stock to shareholders of Health Net, Inc. (NYSE: HNT)…
Why Amgen’s Future Is Looking Bright
Amgen is slowly getting closer to an FDA final decision for its first-of-a-kind cancer therapy, talimogene laherparepvec (T-Vec).
Drug Company to Offer $750 Pill for $1
On Thursday when a generic drug company based in San Diego said it will produce an alternative to the $750 per pill Daraprim.
4 Top Merrill Lynch Dividend-Paying Pharmaceutical Stocks to Buy Now
24/7 Wall St. screened the Merrill Lynch research universe for pharmaceutical stocks paying solid dividends that are rated Buy, and found four outstanding companies.
How FDA Warning Could Spell Disaster for AbbVie and Opportunity for Gilead
ThinkstockThe U.S. Food and Drug Administration (FDA) issued a warning that hepatitis C treatments, Viekira Pak and Technivie, can cause serious liver injury mostly in patients with underlying advanced liver disease. The markets reacted…
Merrimack Pharma Wins FDA Approval of Metastatic Pancreatic Cancer Drug
Merrimack Pharmaceuticals saw its shares halted for "news pending" due to an approval from the FDA.
Community Health Systems Rocked on Lower Guidance, Hospital Woes Continue
ThinkstockCommunity Health Systems Inc. (NYSE: CYH) is showing that the weakness in hospital and medical care facilities may not be over. Its preliminary financial and operating guidance has bushwhacked its shares on Thursday. Net…
Envision Falls Short on Earnings and Guidance
Envision Healthcare was leading the bears in Thursday’s trading session after reporting its third-quarter earnings
Viventia Files for IPO
Viventia Bio has filedwith the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Eli Lilly Rises on Bottom Line Beat
Eli Lilly reported mixed third-quarter financial results on Thursday before the markets opened.
The Strongest Performing Biotech in 2015 Is a Surprise
ThinkstockBiotech is still in a rut for 2015, with stocks year to date being essentially unchanged. Since January 1, the Biotechnology Index is up only 0.3%, pretty much breakeven. While the first half of…
Marijuana Use Doubles in 10 Years
If the federal government eventually makes pot use legal across the country, the decision will not come without substantial medical risks.
Neogenomics Gears Up to Acquire GE’s Clarient
ThinkstockNeogenomics Inc. (NASDAQ: NEO) is leading the bulls in Wednesday’s trading session on news of an acquisition. The company announced that it has reached an agreement to acquire Clarient and its wholly-owned subsidiary Clarient…